Plasmatic coagulation and fibrinolytic factors
| Prothrombic risk factors . | PRED group n = 25 . | DEXA group n = 32 . | P . |
|---|---|---|---|
| Fibrinogen, mg/dL | 43 (10-80) | 101 (43-481) | < .001 |
| Antithrombin activity, % | 56 (41-90) | 75 (35-111) | .002 |
| Protein C activity, % | 68 (45-136) | 72 (53-136) | .330 |
| Free-protein S antigen, % | 55 (28-90) | 64 (44-108) | .020 |
| Plasminogen activity, % | 47 (29-78) | 53 (29-101) | .021 |
| von Willebrand factor antigen, % | 108 (68-172) | 214 (100-442) | .0004 |
| Prothrombic risk factors . | PRED group n = 25 . | DEXA group n = 32 . | P . |
|---|---|---|---|
| Fibrinogen, mg/dL | 43 (10-80) | 101 (43-481) | < .001 |
| Antithrombin activity, % | 56 (41-90) | 75 (35-111) | .002 |
| Protein C activity, % | 68 (45-136) | 72 (53-136) | .330 |
| Free-protein S antigen, % | 55 (28-90) | 64 (44-108) | .020 |
| Plasminogen activity, % | 47 (29-78) | 53 (29-101) | .021 |
| von Willebrand factor antigen, % | 108 (68-172) | 214 (100-442) | .0004 |
Median (range) values of plasmatic coagulation and fibrinolytic factors during maximum CASP activity on days 27 to 33 in children during induction therapy. BFM 90/95 protocol (PRED group) versus BFM 2000 protocol (DEXA group).